Opportunities for nanomaterials in enzyme therapy DOI Creative Commons
Beatriz Torres-Herrero, Ilaria Armenia,

Cecilia Ortiz

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 372, P. 619 - 647

Published: June 29, 2024

In recent years, enzyme therapy strategies have rapidly evolved to catalyze essential biochemical reactions with therapeutic potential. These approaches hold particular promise in addressing rare genetic disorders, cancer treatment, neurodegenerative conditions, wound healing, inflammation management, and infectious disease control, among others. There are several primary reasons for the utilization of enzymes as therapeutics: their substrate specificity, biological compatibility, ability generate a high number product molecules per unit. features encouraged application replacement where serves agent rectify abnormal metabolic physiological processes, prodrug initiates clinical effect by activating prodrugs, dynamic or starving acts upon host molecules. Currently, there >20 commercialized products based on enzymes, but approval rates considerably lower than other biologicals. This has stimulated nanobiotechnology last years develop nanoparticle-based solutions that integrate enzymes. approach aims enhance stability, prevent rapid clearance, reduce immunogenicity, even enable spatio-temporal activation catalyst. comprehensive review delves into emerging trends emphasis synergistic opportunities presented incorporating nanomaterials. Such integration holds enhancing existing therapies paving way innovative nanotherapeutic approaches.

Language: Английский

RNA modifications in physiology and disease: towards clinical applications DOI Open Access
Sylvain Delaunay, Mark Helm, Michaela Frye

et al.

Nature Reviews Genetics, Journal Year: 2023, Volume and Issue: 25(2), P. 104 - 122

Published: Sept. 15, 2023

Language: Английский

Citations

126

Amino Acid Metabolism in Cancer Drug Resistance DOI Creative Commons

Hee-Chan Yoo,

Jung Min Han

Cells, Journal Year: 2022, Volume and Issue: 11(1), P. 140 - 140

Published: Jan. 2, 2022

Despite the numerous investigations on resistance mechanisms, drug in cancer therapies still limits favorable outcomes patients. The complexities of inherent characteristics tumors, such as tumor heterogeneity and complicated interaction within microenvironment, hinder efforts to overcome cells, requiring innovative approaches. In this review, we describe recent studies offering evidence for essential roles amino acid metabolism driving cells. Amino acids support cells counteracting by maintaining redox homeostasis, sustaining biosynthetic processes, regulating epigenetic modification, providing metabolic intermediates energy generation. addition, impacts anticancer immune responses, creating an immunosuppressive or immunoeffective microenvironment. A comprehensive understanding it relates therapeutic mechanisms will improve strategies.

Language: Английский

Citations

73

Multifunctional nanomedicines-enabled chemodynamic-synergized multimodal tumor therapy via Fenton and Fenton-like reactions DOI Creative Commons
Haiyan Gao,

Zhiping Cao,

Huanhuan Liu

et al.

Theranostics, Journal Year: 2023, Volume and Issue: 13(6), P. 1974 - 2014

Published: Jan. 1, 2023

Chemodynamic therapy (CDT) is well-known for using the tumor microenvironment to activate Fenton reaction or Fenton-like generate strong oxidative hydroxyl radicals tumor-specific treatment. It highly selective and safe, without depth limitation of tissue penetration, shows its potential as a new green therapeutic method with great clinical application. However, catalytic efficiency reagents involved in severely affected by inherent microenvironmental limitations tumors strict reaction-dependent conditions. With increasing application nanotechnology medical field, combined therapies based on different types functional nanomaterials have opened up avenues development next-generation CDT-enhanced system. This review will comprehensively exemplify representative results CDT other antitumor such chemotherapy, phototherapy, sonodynamic therapy, radiation magnetic hyperthermia immunotherapy, starvation gas gene oncosis combination thereof improving from hundreds latest literature, introduce strategies ingenious design nanomedicines regulations enhance further summarize challenges future perspective CDT-based multimodal anticancer therapy.

Language: Английский

Citations

64

Amino acid metabolism in tumor biology and therapy DOI Creative Commons
Jie Chen,

Likun Cui,

Shaoteng Lu

et al.

Cell Death and Disease, Journal Year: 2024, Volume and Issue: 15(1)

Published: Jan. 13, 2024

Abstract Amino acid metabolism plays important roles in tumor biology and therapy. Accumulating evidence has shown that amino acids contribute to tumorigenesis immunity by acting as nutrients, signaling molecules, could also regulate gene transcription epigenetic modification. Therefore, targeting will provide new ideas for treatment become an therapeutic approach after surgery, radiotherapy, chemotherapy. In this review, we systematically summarize the recent progress of malignancy their interaction with signal pathways well effect on microenvironment Collectively, highlight potential application future expectation.

Language: Английский

Citations

64

Altered metabolism in cancer: insights into energy pathways and therapeutic targets DOI Creative Commons
Muhammad Tufail, Canhua Jiang, Ning Li

et al.

Molecular Cancer, Journal Year: 2024, Volume and Issue: 23(1)

Published: Sept. 18, 2024

Language: Английский

Citations

62

Recent developments on other platinum metal complexes as target-specific anticancer therapeutics DOI

Thimma Subramanian Prathima,

Badruzzaman Choudhury,

Md Gulzar Ahmad

et al.

Coordination Chemistry Reviews, Journal Year: 2023, Volume and Issue: 490, P. 215231 - 215231

Published: May 19, 2023

Language: Английский

Citations

44

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy DOI Creative Commons

Qinglong Ma,

Wenyang Zhang, Kongming Wu

et al.

Molecular Cancer, Journal Year: 2025, Volume and Issue: 24(1)

Published: Jan. 13, 2025

Abstract KRAS is one of the most mutated genes, driving alternations in metabolic pathways that include enhanced nutrient uptaking, increased glycolysis, elevated glutaminolysis, and heightened synthesis fatty acids nucleotides. However, beyond mechanisms KRAS-modulated cancer metabolisms remain incompletely understood. In this review, we aim to summarize current knowledge on KRAS-related alterations cells explore prevalence significance mutation shaping tumor microenvironment influencing epigenetic modification via various molecular activities. Given rely these changes sustain cell growth survival, targeting processes may represent a promising therapeutic strategy for KRAS-driven cancers.

Language: Английский

Citations

4

Impact of cancer metabolism on therapy resistance – Clinical implications DOI Creative Commons
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge

et al.

Drug Resistance Updates, Journal Year: 2021, Volume and Issue: 59, P. 100797 - 100797

Published: Dec. 1, 2021

Language: Английский

Citations

89

Metabolism and polarization regulation of macrophages in the tumor microenvironment DOI
Jia Wang, Shichao Mi,

Muyao Ding

et al.

Cancer Letters, Journal Year: 2022, Volume and Issue: 543, P. 215766 - 215766

Published: June 8, 2022

Language: Английский

Citations

53

Biomedical application of aggregation-induced emission luminogen-based fluorescent sensors DOI Creative Commons
Yanhong Duo,

Zhongyuan Xiang,

Ge Gao

et al.

TrAC Trends in Analytical Chemistry, Journal Year: 2023, Volume and Issue: 167, P. 117252 - 117252

Published: Aug. 25, 2023

Fluorescent biosensors are powerful analytical tools that have been widely employed in a range of vitro and vivo biomedical applications. However, traditional fluorophores exhibit aggregation-caused quenching (ACQs) effects hinder their use the development more advanced fluorescent biosensors. The discovery by Prof. Ben Zhong Tang aggregation-induced emission (AIE) luminogen (AIEgen) opposite to those impacted ACQ provides unique opportunities for design novel "turn-on" These AIEgens thus attracted extensive interest from researchers seeking leverage properties produce effective biosensing molecules, strategies, associated A wide array with structures, functional groups, optical properties, applications developed recent years. In present review, we provide comprehensive overview advances field AIEgen-based biosensor discuss future clinical prospects these molecules. Through discussions, hope strong evidence-based foundation further efforts aimed at producing increasingly

Language: Английский

Citations

26